Principal Scientist – Bioanalysis

Can you take a leading role across bioanalysis?

If you have solid experience across bioanalytical assays, and you are looking for a job with major freedom to perform and massively impact in a cross-functional project driven environment, we have the perfect job for you. LEO Pharma has set the very ambitious goal to become the world’s preferred dermatology care partner. To make this come true we are expanding our pipeline within small molecules as well as biologics, and that is why we need you to unfold all of your knowledge and ideas.

Bioanalytical assays and biomarkers in collaboration with CRO’s

As Principal Scientist in our Preclinical Development team you will focus on bioanalytical assays. In Preclinical Development we have outsourced lab-activities to CRO’s meaning that your role is to set up, lead and monitor studies at CROs, rather than being in the lab conducting experiments on your own. Your primary tasks will be to:

• Plan, set up, coordinate and monitor method development and validation of bioanalytical methods at CROs – for TK/PK and immunogenicity assessment in toxicology species and in humans
• Initiate and monitor ongoing bioanalysis in animal studies and clinical trials
• Plan, set up, coordinate and monitor some preclinical DMPK studies and occasionally also coordinate and monitor metabolite screening in preclinical and clinical studies with small molecules

The studies are conducted in conformity with the requirements of the authorities and according to GLP/GCP when necessary.

Biological degree and solid experience across bioanalytical assays

You have a university degree in biological sciences e.g. biology, biochemistry, as MD or pharmacist. This is backed by minimum 10 years’ experience with bioanalysis of which at least 5 must be from the pharma industry or CRO where you have worked in cross-functional and cross-organizational projects. You bring solid expertise from working with bioanalysis in a GLP/GCP driven environment where you have handled preparation of documents such as IB, CTA, IND etc. You also have experience in working closely with CROs.

To succeed, you must thrive in an organisation where the only constant is change and where you will not find manuals and SOP’s for everything you do – we trust you to make the right decisions. As you will have multiple contacts internally and externally you will need an open-minded approach towards different ways of working as well as towards different cultural and professional backgrounds. You like to share knowledge and win as a team yet you are not afraid to take lead on your own, e.g. as the department’s representative in major projects.

Your new team

You will join a small team of highly skilled Scientists in Preclinical Development at LEO Pharma’s headquarters in Ballerup, Greater Copenhagen and 1 experienced Scientist based in Tokyo. Our team comprises three scientists specialised in bioanalysis and six toxicologists. We work in an informal and friendly atmosphere characterised by trust and helpfulness.

Contact and application

Please apply at our website. The deadline is 28 March 2022. We will be reviewing applications on an ongoing basis. If you have any questions, you are very welcome to contact Jakob Michael Back, Director, Preclinical Development, R&D at +45 5389 5153. We look forward to receiving your application.

About LEO Pharma

At LEO Pharma, we are pioneering together. We help people with skin diseases live fulfilling lives by advancing dermatology beyond the skin. We drive dermatology with our knowledge, collaboration and curiosity. We are at the forefront of science in developing new medicines for dermatology. Each one of us at LEO Pharma can make a real impact in our everyday work. Together, we explore new ideas and make them happen. We do this through mutual respect and a shared sense of purpose, rooted in our caring culture and a commitment to helping others. For us, pioneering together is about constantly improving and extending what’s possible for each other, our company, and our patients. LEO Pharma is headquartered in Denmark with a global team of 6,000 people, serving 92 million patients in 130 countries. In 2019, the company generated net sales of DKK 10,805 million. Read more at leo-pharma.com